Targeting a neoantigen derived from a common TP53 mutation
More ammunition for hope, new immunotherapy drugs target two evasive cancer-driving proteins.
https://www.sciencemag.org/news/2021...iving-proteins https://science.sciencemag.org/conte.../6533/eabc8697 |
All times are GMT -7. The time now is 06:12 AM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021